Wegovy, a brand name for semaglutide, is specifically dosed and approved for weight management in adults and adolescents aged 12 and older who have obesity or weight-related conditions such as hypertension, type 2 diabetes, or dyslipidemia
WeightWatchers launches program for users of Ozempic and other weight-loss drugs For those who thought Ozempic would spell the end of diet programs, think again
(2025), in a retrospective cohort study published in the Journal of the American Academy of Dermatology, confirmed an increased incidence of alopecia in GLP-1 receptor agonist users
GLP-1 RAs, particularly liraglutide and semaglutide, have been shown to have a generally positive effect in the treatment of HS
Understanding what's happening inside your body is the first step toward taking control